Molecular profile of residual triple-negative breast cancer: opportunities for post-neoadjuvant therapeutic interventions

Abstract A subset of triple negative breast cancer (TNBC) patients shows resistance to standard neoadjuvant chemotherapy (NAC), resulting in high relapse and mortality risk. This highlights the need for predictive biomarkers and alternative treatment strategies. Targeted molecular profiling was perf...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Nadine S. van den Ende, Marcel Smid, John W. M. Martens, Reno Debets, Agnes Jager, Carolien H. M. van Deurzen
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-05-01
coleção:	npj Breast Cancer
Acesso em linha:	https://doi.org/10.1038/s41523-026-00964-7
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!